Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

The Effect of Topiramate on Etonogestrel Concentrations in Contraceptive Implant Users

Trial Profile

The Effect of Topiramate on Etonogestrel Concentrations in Contraceptive Implant Users

Status: Recruiting
Phase of Trial: Phase I

Latest Information Update: 14 Jun 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Etonogestrel (Primary) ; Topiramate (Primary)
  • Indications Pregnancy
  • Focus Pharmacokinetics
  • Most Recent Events

    • 11 Jun 2019 Planned End Date changed from 31 Jul 2019 to 31 Jul 2020.
    • 11 Jun 2019 Planned primary completion date changed from 30 Jan 2019 to 30 Jan 2020.
    • 22 Mar 2018 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top